Part
Scheduling of Dangerous Drugs
- Mont. Code Ann. § 50-32-201— General criteria to be considered
- Mont. Code Ann. § 50-32-202— Designation of drug as dangerous drug
- Mont. Code Ann. § 50-32-203— Effect of rescheduling under federal law
- Mont. Code Ann. § 50-32-204— Immediate precursors
- Mont. Code Ann. § 50-32-205— Nonprescription drugs not to be scheduled
- Mont. Code Ann. § 50-32-206— Use of names of scheduled drugs
- Mont. Code Ann. § 50-32-207— Order forms for drugs in Schedules I and II
- Mont. Code Ann. § 50-32-208— Prescription and medical requirements for scheduled drugs -- penalty
- Mont. Code Ann. § 50-32-209— Republication of schedules
- Mont. Code Ann. § 50-32-210— through 50-32-220 reserved
- Mont. Code Ann. § 50-32-221— Criteria for placement of drug in Schedule I
- Mont. Code Ann. § 50-32-222— Specific dangerous drugs included in Schedule I
- Mont. Code Ann. § 50-32-223— Criteria for placement of drug in Schedule II
- Mont. Code Ann. § 50-32-224— Specific dangerous drugs included in Schedule II
- Mont. Code Ann. § 50-32-225— Criteria for placement of drug in Schedule III
- Mont. Code Ann. § 50-32-226— Specific dangerous drugs included in Schedule III
- Mont. Code Ann. § 50-32-227— Board authorized to exempt certain compounds, mixtures, or preparations from Schedule III
- Mont. Code Ann. § 50-32-228— Criteria for placement of drug in Schedule IV
- Mont. Code Ann. § 50-32-229— Specific dangerous drugs included in Schedule IV
- Mont. Code Ann. § 50-32-230— Board authorized to exempt certain compounds, mixtures, or preparations from Schedule IV
- Mont. Code Ann. § 50-32-231— Criteria for placement of drug in Schedule V
- Mont. Code Ann. § 50-32-232— Specific dangerous drugs included in Schedule V
- Mont. Code Ann. § 50-32-233— Exempt anabolic steroid products